Test environment running 7.6.6

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Water soluble, hydrolytically stable derivatives of the antitumor drug titanocene dichloride and binding studies with nucleotides

Loading...
Thumbnail Image

Date

Authors

Mokdsi, George
Harding, Margaret

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

The rate of hydrolysis of the aromatic rings of Cp2TiX2 and the dimethylsubstituted derivatives (MeCp)2TiX2 [X=Cl, O2CCH2NH3Cl], in aqueous solutions at pH 2-8 have been studied by 1H-NMR spectroscopy. Rapid hydrolysis of both the halide and cyclopentadienyl ligands in Cp2TiX2 [X=Cl, O2CCH2NH3Cl] occurs to give predominantly insoluble precipitates at pH 7. In contrast, under the same experimental conditions, the predominant species present in aqueous solutions of (MeCp)2TiX2 [X=Cl, O2CCH2NH3Cl] at pH 2-8 contains both methycyclopentadienyl rings metal bound. At pH<5, Cp2TiX2 and (MeCp)2TiX2 form similar complex(es) with purine nucleotides. However, at pH〉5, while stable adducts between nucleotides and Cp2TiX2 are not formed, in the presence of 1 equiv. of 5′-dAMP or 5′-dGMP, (MeCp)2TiX2 formed complex(es) which were stable for 24 h. These results suggest that formation of stable chelates between (MeCp)2TiX2 and nucleic acid constituents in vivo is possible.

Description

Citation

Source

Journal of Organometallic Chemistry

Book Title

Entity type

Access Statement

License Rights

Restricted until

2037-12-31